Chapter

Current trials in renal cell carcinoma

Paul Nathan and Anup Vinayan

in Renal Cancer

Published on behalf of Oxford University Press

ISBN: 9780199562312
Published online September 2011 | e-ISBN: 9780199607402 | DOI: http://dx.doi.org/10.1093/med/9780199562312.003.0009

Series: Oxford Oncology Library

Current trials in renal cell carcinoma

Show Summary Details

Preview

• The advent of clinically useful targeted therapies for renal cell carcinoma (RCC) has resulted in a large expansion in clinical trial activity • Current trials focus on identifying optimal sequences and combinations of new agents as well as determining whether the new agents are active in the adjuvant setting • An understanding of mechanisms of resistance to targeted agents would inform the optimal use of new agents • Given the large number of possible combinations and sequences of new therapies that need to be assessed, innovative approaches to clinical trial design need to be considered.

Chapter.  3265 words. 

Subjects: Clinical Oncology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.